Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous neuromodulation.

Matthew R Cooperberg1, Marshall L Stoller

  • 1Department of Urology, University of California, 400 Parnassus Avenue, A-633, Box 0738, San Francisco, CA 94143, USA.

The Urologic Clinics of North America
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between quality of life, intensity of counseling and health literacy amongst patients with nephrolithiasis.

World journal of urology·2026
Same author

Preclinical Evaluation of the Safety of Robotic-Assisted Ureteroscopy and Guided Percutaneous Nephrolithotomy.

Journal of endourology·2026
Same author

Improved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence.

Urolithiasis·2025
Same author

A Multicenter Randomized Controlled Trial of Ambulatory Versus Inpatient Percutaneous Nephrolithotomy.

European urology focus·2025
Same author

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Seminars in nephrology·2025
Same author

Reply by Authors.

The Journal of urology·2025
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Neuromodulation techniques for pelvic floor dysfunction have advanced to minimally invasive peripheral neurostimulation, showing consistent positive outcomes. Future implantable devices will offer patients greater control and hope for this underdiagnosed condition.

Area of Science:

  • Urology
  • Neurology
  • Physical Therapy

Background:

  • Pelvic floor dysfunction (PFD) affects a significant population, often underdiagnosed.
  • Traditional treatments for PFD have limitations in efficacy and invasiveness.

Purpose of the Study:

  • To review the evolution and current status of neuromodulation for PFD.
  • To highlight the benefits of percutaneous peripheral neurostimulation for PFD.
  • To discuss future directions in PFD neuromodulation.

Main Methods:

  • Review of existing literature on neuromodulation techniques for PFD.
  • Analysis of reported outcomes for central sacral stimulation and peripheral neurostimulation.
  • Discussion of emerging technologies and their potential applications.

Related Experiment Videos

Main Results:

  • Neuromodulation has progressed from invasive central sacral stimulation to minimally invasive peripheral neurostimulation.
  • Percutaneous peripheral neurostimulation is well-tolerated and yields consistent positive results for various PFD manifestations.
  • Future implantable devices will enhance patient-controlled stimulation.

Conclusions:

  • Percutaneous peripheral neurostimulation represents a significant advancement in PFD treatment.
  • This modality offers a promising, well-tolerated option for patients with pelvic floor dysfunction.
  • Technological advancements are expected to further improve PFD management through neuromodulation.